Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations

European Journal of Ophthalmology

Volumn 11, Issue 4, 2001, Pages 351-355

  Aras, S ^a   Yilmaz, G ^a   Alpas, I ^a   Baltaci, V ^a   Tayanc E ^a   Aydin, P ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Branch retinal vein occlusion; Central retinal vein occlusion; Factor V Leiden mutation; Prothrombin 20210 G:A mutation; Retinal vein occlusion

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; GUANINE; PROTHROMBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RISK FACTOR;

EID: 0035714424     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210101100406     Document Type: Article

References (28)

1. Central retinal vein occlusion
2. Retinal branch vein occlusion
3. Risk factors for retinal vein thrombosis: A case-control study
4. Risk factors for branch retinal vein occlusion
5. Baseline and early natural history report: The central retinal vein occlusion study
6. Central retinal vein occlusion in young adults
7. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
8. Resistance to activated protein C as a basis for venous thrombosis
9. Peripheral retinal neovascularization and retinal vascular occlusion associated with activated protein C resistance
10. Activated protein C resistance in young adults with central retinal vein occlusion
11. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: A population controlled study
12. Activated protein C resistance: Low incidence in glaucomatous disc hemorrhage and central retinal vein occlusion
13. Activated protein C resistance, factor V Leiden, and central retinal occlusion in young adults
14. Mutation in blood coagulation factor V associated with resistance to activated protein C
15. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V
16. World distribution of factor V Leiden
17. Prevalence of Factor V Leiden in young adults with retinal vein occlusion
18. Heritable thrombophilia and hypofibrinolysis
19. Factor V and antithrombin gene mutations in patients with idiopathic central retinal vein occlusion
20. Factor V Leiden, activated protein C resistance, and retinal vein occlusion
21. A common genetic variation in the 3′-untranslated region of prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
22. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype
23. Mixed retinal thrombosis in a patient carrying prothrombin gene mutation in a homozygote state
24. The prothrombin gene G20210A mutation and platelet glycoprotein IIIa polymorphism PIA2 in patients with central retinal vein occlusion
25. Lack of activated protein C resistance in healthy Hong Kong Chinese blood donors correlation with absence of Arg506-Gln mutation of factor V
26. Prevalence of factor V gene mutation among myocardial infarction patients and healthy controls is higher in Sweden than in other countries
27. Risk factors in central retinal vein occlusion and activated protein C resistance
28. Frequency of Factor V (1691 G→A) mutation in the Turkish population